50
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Solifenacin at 3 Years: A Review of Efficacy and Safety

, MD, , MD & , MD
Pages 85-91 | Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Richard Nicholas, Carolyn Young & Tim Friede. (2010) Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. Expert Opinion on Drug Safety 9:6, pages 905-915.
Read now

Articles from other publishers (12)

Abhishek Chandna, Santosh Kumar, Kalpesh M Parmar, Aditya P Sharma, Sudheer K Devana, Uttam K Mete & Shrawan K Singh. (2021) Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: A double blinded randomized clinical trial. Urologia Journal 89:4, pages 589-596.
Crossref
Hsin-Yen Cho, Tzu-Hsien Chuang & Sheng-Nan Wu. (2021) The Effectiveness in Activating M-Type K+ Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action. International Journal of Molecular Sciences 22:22, pages 12399.
Crossref
Linda Cardozo, Sender Herschorn, Robert Snijder, Emad Siddiqui & Christopher R. Chapple. (2016) Does BMI, gender or age affect efficacy/tolerability of solifenacin in the management of overactive bladder?. International Urogynecology Journal 28:3, pages 477-488.
Crossref
Krystal J. Thomas-White, Evann E. Hilt, Cynthia Fok, Meghan M. Pearce, Elizabeth R. Mueller, Stephanie Kliethermes, Kristin Jacobs, Michael J. Zilliox, Cynthia Brincat, Travis K. Price, Gina Kuffel, Paul Schreckenberger, Xiaowu Gai, Linda Brubaker & Alan J. Wolfe. (2015) Incontinence medication response relates to the female urinary microbiota. International Urogynecology Journal 27:5, pages 723-733.
Crossref
Richard S Nicholas, Tim Friede, Sally Hollis & Carolyn A Young. (2015) Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Richard M. Eglen. 2012. Muscarinic Receptors. Muscarinic Receptors 3 28 .
Turgut Topol, Catherine Schuler, Robert E. Leggett, Tasmina Hydery, Sandra Benyamin & Robert M. Levin. (2011) Effect of solifenacin plus and minus antioxidant supplements on the response to experimental outlet obstruction and overactive bladder dysfunction in rabbits—Part 2. Urological Science 22:4, pages 141-146.
Crossref
Turgut Topol, Catherine Schuler, Robert E. Leggett, Tasmina Hydery, Sandra Benyamin & Robert M. Levin. (2011) Effect of solifenacin with and without antioxidant supplements on the response to experimental outlet obstruction and overactive bladder dysfunction in rabbits: Part 1. Urological Science 22:3, pages 110-115.
Crossref
R Mappilakkandy & AK Mistri. (2010) Anticholinergics for urge incontinence. Reviews in Clinical Gerontology 20:1, pages 30-41.
Crossref
Oxana Doroshyenko & Uwe Fuhr. (2009) Clinical Pharmacokinetics and Pharmacodynamics of Solifenacin. Clinical Pharmacokinetics 48:5, pages 281-302.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:2.
Crossref
Richard S Nicholas, Tim Friede, Sally Hollis & Carolyn A Young. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.